Read More Pharma Industry News Cogent Biosciences (NASDAQ: COGT) slips after hours as insider sales prompt investor scrutiny Cogent Biosciences stock fell after hours on insider sales by multiple executives. Find out why it matters now and what it means for investors going forward. bySrinathDecember 31, 2025